Fix reorder columns #111
GitHub Actions / Unit Tests Summary
failed
Jul 23, 2024 in 0s
3 fail, 88 skipped, 250 pass in 1m 0s
Annotations
Check warning on line 0 in tables_ADA_adat04a
github-actions / Unit Tests Summary
tables_ADA_adat04a.qmd_result_v1_development (tables_ADA_adat04a) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-ADA-adat04a.R:1:1')
Snapshot of code has changed (variant 'development'):
old[4:27] vs new[4:27]
Baseline Prevalence and Incidence of Treatment Emergent NAbs
Protocol: A: Drug X Antibody
- ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination <Missing> B: Placebo All Drug X
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=0) (N=134) (N=266)
- ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of NAbs
+ Baseline Prevalence of NAbs
- Baseline evaluable patients for ADA 134 132 0 0 266
+ Baseline evaluable patients for ADA 134 132 0 0 266
- Patients with a positive ADA sample at baseline 63 64 0 0 127
+ Patients with a positive ADA sample at baseline 63 64 0 0 127
- Patients with a positive NAb sample at baseline 0 0 0 0 0
+ Patients with a positive NAb sample at baseline 0 0 0 0 0
- Patient with no positive NAb samples at baseline 0 0 0 0 0
+ Patient with no positive NAb samples at baseline 0 0 0 0 0
- Incidence of Treatment Emergent NAbs
+ Incidence of Treatment Emergent NAbs
- Post-baseline evaluable patients for ADA 134 132 0 0 266
+ Post-baseline evaluable patients for ADA 134 132 0 0 266
- Patients positive for ADA 66 59 0 0 125
+ Patients positive for ADA 66 59 0 0 125
- Patients positive for Treatment Emergent NAb 0 0 0 0 0
+ Patients positive for Treatment Emergent NAb 0 0 0 0 0
- Treatment-induced NAb 0 0 0 0 0
+ Treatment-induced NAb 0 0 0 0 0
- Treatment-enhanced NAb 0 0 0 0 0
+ Treatment-enhanced NAb 0 0 0 0 0
- Patients negative for NAb 0 0 0 0 0
+ Patients negative for NAb 0 0 0 0 0
- Treatment unaffected 0 0 0 0 0
+ Treatment unaffected 0 0 0 0 0
- ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NAb = Neutralizing Antibodies ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient for ADA = a patient with an ADA assay result from a baseline sample(s)
Baseline evaluable patient for NAb = a patient with a NAb assay result from a baseline sample(s)
* Run `testthat::snapshot_accept('development/tables-ADA-adat04a')` to accept the change.
* Run `testthat::snapshot_review('development/tables-ADA-adat04a')` to interactively review the change.
Check warning on line 0 in tables_ADA_adat04b
github-actions / Unit Tests Summary
tables_ADA_adat04b.qmd_result_v1_development (tables_ADA_adat04b) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-ADA-adat04b.R:1:1')
Snapshot of code has changed (variant 'development'):
old[4:24] vs new[4:24]
Baseline Prevalence and Incidence of Neutralizing Antibodies (NAbs)
Protocol: A: Drug X Antibody
- ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- A: Drug X C: Combination <Missing> B: Placebo All Drug X
+ A: Drug X C: Combination <Missing> B: Placebo All Drug X
- (N=134) (N=132) (N=0) (N=134) (N=266)
+ (N=134) (N=132) (N=0) (N=134) (N=266)
- ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
- Baseline Prevalence of NAbs
+ Baseline Prevalence of NAbs
- Baseline evaluable patients for ADA 134 132 0 0 266
+ Baseline evaluable patients for ADA 134 132 0 0 266
- Patients with a positive ADA sample at baseline 63 64 0 0 127
+ Patients with a positive ADA sample at baseline 63 64 0 0 127
- Patients with a positive NAb sample at baseline 0 0 0 0 0
+ Patients with a positive NAb sample at baseline 0 0 0 0 0
- Patients with no positive NAb sample at baseline 0 0 0 0 0
+ Patients with no positive NAb sample at baseline 0 0 0 0 0
- Incidence of NAbs
+ Incidence of NAbs
- Post-baseline evaluable patients for ADA 134 132 0 0 266
+ Post-baseline evaluable patients for ADA 134 132 0 0 266
- Patients positive for ADA 66 59 0 0 125
+ Patients positive for ADA 66 59 0 0 125
- Patients positive for NAb 0 0 0 0 0
+ Patients positive for NAb 0 0 0 0 0
- Patients negative for NAb 134 132 0 0 266
+ Patients negative for NAb 134 132 0 0 266
- ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
+ —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
NAb = Neutralizing Antibodies ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies) Baseline evaluable patient for ADA = a patient with an ADA assay result from a baseline sample(s) Baseline evaluable patient for NAb = a patient with a NAb assay result from a baseline sample(s) Post-baseline evaluable patient for ADA = a patient with an ADA assay result from at least one post-baseline sample Post-baseline evaluable patient for NAb = a patient with a NAb assay result from at least one post-baseline sample Number of patients positive for ADA = the number of post-baseline evaluable patients for ADA determined to have Treatment Emergent ADA during the study period.
Number of patients positive for NAb = the number (and percentage) of post-baseline evaluable patients for ADA determined to have at least one positive post-baseline NAb result during the study period. Number of patients negative for NAb = number of post-baseline evaluable patients with all negative post-baseline NAb results.
* Run `testthat::snapshot_accept('development/tables-ADA-adat04b')` to accept the change.
* Run `testthat::snapshot_review('development/tables-ADA-adat04b')` to interactively review the change.
Check warning on line 0 in tables_efficacy_rbmit01
github-actions / Unit Tests Summary
tables_efficacy_rbmit01.qmd_result_v1_development (tables_efficacy_rbmit01) failed
tlg.catalog.pkg.Rcheck/tests/testthat/junit-result.xml [took 0s]
Raw output
Snapshot of code has changed (variant 'development'): ('test-tables-efficacy-rbmit01.R:1:1')
Snapshot of code has changed (variant 'development'):
old[11:33] vs new[11:33]
Relative Reduction (%) 5.7%
p-value (RBMI) 0.8932
5
- Adjusted Mean (SE) -4.255 (0.653) -2.857 (0.634)
+ Adjusted Mean (SE) -4.263 (0.660) -2.863 (0.634)
- 95% CI (-5.546, -2.965) (-4.109, -1.605)
+ 95% CI (-5.567, -2.958) (-4.114, -1.611)
- Difference in Adjusted Means (SE) 1.398 (0.915)
+ Difference in Adjusted Means (SE) 1.400 (0.925)
- 95% CI (-0.409, 3.205)
+ 95% CI (-0.428, 3.228)
- Relative Reduction (%) -32.9%
+ Relative Reduction (%) -32.8%
- p-value (RBMI) 0.1285
+ p-value (RBMI) 0.1324
6
- Adjusted Mean (SE) -6.413 (0.712) -4.166 (0.692)
+ Adjusted Mean (SE) -6.429 (0.711) -4.163 (0.687)
- 95% CI (-7.821, -5.005) (-5.533, -2.800)
+ 95% CI (-7.834, -5.023) (-5.520, -2.806)
- Difference in Adjusted Means (SE) 2.246 (1.005)
+ Difference in Adjusted Means (SE) 2.265 (0.987)
- 95% CI (0.260, 4.232)
+ 95% CI (0.315, 4.216)
- Relative Reduction (%) -35.0%
+ Relative Reduction (%) -35.2%
- p-value (RBMI) 0.0269
+ p-value (RBMI) 0.0231
7
- Adjusted Mean (SE) -7.652 (0.775) -4.939 (0.771)
+ Adjusted Mean (SE) -7.677 (0.784) -4.864 (0.764)
- 95% CI (-9.185, -6.120) (-6.465, -3.414)
+ 95% CI (-9.228, -6.126) (-6.375, -3.353)
- Difference in Adjusted Means (SE) 2.713 (1.099)
+ Difference in Adjusted Means (SE) 2.813 (1.111)
- 95% CI (0.538, 4.888)
+ 95% CI (0.615, 5.011)
- Relative Reduction (%) -35.5%
+ Relative Reduction (%) -36.6%
- p-value (RBMI) 0.0149
+ p-value (RBMI) 0.0125
* Run `testthat::snapshot_accept('development/tables-efficacy-rbmit01')` to accept the change.
* Run `testthat::snapshot_review('development/tables-efficacy-rbmit01')` to interactively review the change.
Loading